GlassScriptPhysician profile
Arif Ajmeri
NPI 1710322268
$1,355.29
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $346 · 2020: $69.58 · 2021: $302 · 2022: $168 · 2023: $231 · 2024: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $469.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $469.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $207.19 | 2019-2024 | |
| Amgen INC. | $185.05 | 2019-2024 | Otezla, Repatha |
| Glaxosmithkline, LLC. | $159.60 | 2019-2024 | Shingrix, Arexvy, Bexsero |
| Merck Sharp & Dohme LLC | $153.21 | 2019-2024 | Gardasil 9, Vaxelis, Gardasil |
| Pfizer INC. | $136.79 | 2019-2024 | |
| Novo Nordisk INC | $64.47 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $62.44 | 2021 | |
| Exact Sciences Corporation | $53.50 | 2023-2024 | Cologuard Collection Kit |
| Abbvie INC. | $43.98 | 2021 | |
| Lilly USA, LLC | $38.49 | 2019-2024 | Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.03 | 2022-2023 | Jardiance |
| Abbott Laboratories | $35.74 | 2022-2023 | Freestyle Libre 3 |
| Allergan, INC. | $26.51 | 2019 | |
| Sanofi-Aventis U.S. LLC | $25.90 | 2020-2021 | |
| Scilex Pharmaceuticals INC. | $25.17 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $24.91 | 2023 | Vpriv |
| Tactile Systems Technology INC | $19.88 | 2024 | Entre Plus, Flexitouch Plus |
| Astrazeneca Pharmaceuticals LP | $16.97 | 2024 | |
| Mylan Specialty L.P. | $14.56 | 2021 | |
| Insulet Corporation | $14.00 | 2019 | |
| Organon LLC | $9.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arif Ajmeri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.